Ali Can Kayaaslan

Ali Can Kayaaslan

Auto-generated profile, based on publicly available information

Ali Can Kayaaslan

Department of Thoracic Surgery, University of Health Sciences, Atatürk Sanatoryum Training and Research Hospital, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2025 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
İTİlteriş Türk
İlteriş Türk
MÇMehmet Çetin
Mehmet Çetin
NSNecati Solak
Necati Solak
AKAli Can Kayaaslan
Ali Can Kayaaslan
NGNesrin Gürçay
Nesrin Gürçay
SGSelim Şakir Erkmen Gülhan
Selim Şakir Erkmen Gülhan
Background: Several studies have been conducted to identify the parameters associated with the aggressive course of pleuropulmonary solitary fibrous tumors (SFT) following surgical treatment, and various classification systems have been proposed for assessing risk. Methods: The surgical outcomes of patients with pleuropulmonary SFT who underwent surgery between 2009 and 2024 at our center were retrospectively evaluated. Parameters of patients who experienced recurrence during follow-up were analyzed, and the risk classification systems proposed by Demicco were tested on our patient cohort. The pozitron emision tomography/ computed tomography (PET/CT) standart uptake value(SUVmax), which was significantly associated with recurrence, was incorporated into the modified Demicco classification, and a new classification model was developed and compared with existing models. Results: Among the 79 included patients, 21.5% had intraparenchymal tumors, which were excised along with various parenchymal resections, while pleural tumors underwent mass excision. The postoperative follow-up period was 108.16 ± 44.09 months, during which 7.6% of patients experienced recurrence. Tumor size (p = 0.023), mitotic index (p < 0.001), presence of necrosis (p = 0.007), and PET/CT SUVmax value (p = 0.005) were found to be significantly associated with recurrence. The PET/CT SUVmax value, which was not included in Demicco’s classifications, ranged from 1.12 to 7.98, with a cutoff value of 4.50. The addition of SUVmax to the modified Demicco classification categorized all patients with recurrence into the high-risk group, and the new classification model strongly differentiated recurrence (p < 0.01, 100% sensitivity, 71.43% specificity). Conclusion: The incorporation of SUVmax into the modified Demicco classification system for pleuropulmonary SFT provides a more significant prediction of recurrence.